The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.

The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.

The invention relates to a method for preparing a lipid-rich microalgal flour, which comprises the following steps: (a) providing a microalgal biomass comprising more than 50% of lipids by dry weight of biomass; (b) lyzing the microalgae, (c) concentrating the microalgal lyzate to a solids content of more than 25% by weight, preferably to a solids content of between 35% and 50% by weight, (d) applying a heat treatment to the lyzate thus concentrated, (e) homogenizing at high pressure the lyzate obtained in step (d), so as to obtain a stable emulsion, (f) drying said emulsion to obtain the microalgal flour.

The invention relates to a method for preparing a lipid-rich microalgal flour, which comprises the following steps: (a) providing a microalgal biomass comprising more than 50% of lipids by dry weight of biomass; (b) lyzing the microalgae, (c) concentrating the microalgal lyzate to a solids content of more than 25% by weight, preferably to a solids content of between 35% and 50% by weight, (d) applying a heat treatment to the lyzate thus concentrated, (e) homogenizing at high pressure the lyzate obtained in step (d), so as to obtain a stable emulsion, (f) drying said emulsion to obtain the microalgal flour.

Methods and compositions for increasing intestinal transport of nutrients or growth performance in the offspring of an animal are described. More specifically, a feed composition comprising an omega-3 fatty acid-containing composition for increasing intestinal transport of nutrients or growth performance in the offspring of the animal, and methods therefor, are described.

Disclosed herein are new cannabis compositions. In one embodiment, these new cannabis compositions are beverages, such as tea. In one embodiment, these new cannabis compositions are dehydrated beverages, such as powders or crystalline forms, which can be mixed with other components, like tea, and added to water.

Oral formulations for promoting eye health, and in particular for preventing or treating macular degeneration, are disclosed, containing zeaxanthin, a carotenoid pigment, and at least two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate the production of glutathione. Processes are disclosed for identifying ocular-active nutrients that will interact in a synergistic and potentiating manner with zeaxanthin, to provide better and more effective protection, for eye health, than can be provided by zeaxanthin alone. Additional optional agents include zinc, vitamin E, and vitamin C.

The present invention relates to the industrial cultivation of protists for producing lipids containing polyunsaturated fatty acids (PUFA), in particular eicosapentaenoic acid (EPA) and arachidonic acid (ARA).

The invention provides a meat analogue product comprising from 10-60% by weight vegetable protein, at least 0.1% by weight of binding agent, from 10-60% by weight of water, and from 5-40% by weight of non-hydrogenated vegetable fat; wherein the non-hydrogenated vegetable fat has a saturated fatty acid (SAFA) content of at least 40% by weight, and a solid fat content (SFC) at 20° C. of at least 20%. The invention also provides a method for making the meat analogue product.

The invention provides a meat analogue product comprising from 10-60% by weight vegetable protein, at least 0.1% by weight of binding agent, from 10-60% by weight of water, and from 5-40% by weight of non-hydrogenated vegetable fat; wherein the non-hydrogenated vegetable fat has a saturated fatty acid (SAFA) content of at least 40% by weight, and a solid fat content (SFC) at 20° C. of at least 20%. The invention also provides a method for making the meat analogue product.